Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Bai

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Medicine|June 25, 2019
A 12-year review of patient-reported outcomes after reduction mammoplasty in patients with high body mass indexLedibabari M Ngaage, Jennifer Bai, Selim Gebran, et al.
Cancer Research|September 4, 2012
Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 familyLynn M Pouliot, Yu-Chi Chen, Jennifer Bai, et al.
Plastic and Reconstructive Surgery|January 25, 2019
Postoperative Outcomes in Obese Patients That Undergo Ventral Hernia Repair versus Ventral Hernia Repair with Concurrent PanniculectomySilviu C Diaconu, Colton H L McNichols, Sara AlFadil, et al.
Annals of Plastic Surgery|January 20, 2021
The Use of Botulinum Toxin to Prevent Anastomotic Thrombosis and Promote Flap Survival: A Bridge to Developing Clinical StudiesAbbas M Hassan, Ava G Chappell, Riley M Boyd, et al.
Eplasty|August 2, 2019
Longevity of Outcomes Following Reduction MammoplastyJennifer Bai, Carly M Rosen, Ledibabari M Ngaage, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Medicine|June 25, 2019
A 12-year review of patient-reported outcomes after reduction mammoplasty in patients with high body mass indexLedibabari M Ngaage, Jennifer Bai, Selim Gebran, et al.
Cancer Research|September 4, 2012
Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 familyLynn M Pouliot, Yu-Chi Chen, Jennifer Bai, et al.
Plastic and Reconstructive Surgery|January 25, 2019
Postoperative Outcomes in Obese Patients That Undergo Ventral Hernia Repair versus Ventral Hernia Repair with Concurrent PanniculectomySilviu C Diaconu, Colton H L McNichols, Sara AlFadil, et al.
Annals of Plastic Surgery|January 20, 2021
The Use of Botulinum Toxin to Prevent Anastomotic Thrombosis and Promote Flap Survival: A Bridge to Developing Clinical StudiesAbbas M Hassan, Ava G Chappell, Riley M Boyd, et al.
Eplasty|August 2, 2019
Longevity of Outcomes Following Reduction MammoplastyJennifer Bai, Carly M Rosen, Ledibabari M Ngaage, et al.
Pageof 2